Screener
Senti Biosciences SNTI Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
Revenue$22.0KMiss by $978.0K
EPS-$0.38Beat by $0.05
Revenue estimate$1.0M
EPS estimate-$0.43
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$15.9K
EPS estimate-$0.21
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Senti Biosciences report Q4 2025 earnings?
- Senti Biosciences (SNTI) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were Senti Biosciences's Q4 2025 revenue and EPS?
- Senti Biosciences reported revenue of $22.0K and eps of $-0.38 for Q4 2025.
- Did Senti Biosciences beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $1.0M by $978.0K. EPS beat the consensus estimate of $-0.43 by $0.05.
- How did Senti Biosciences's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 99.6% from $5.9M a year earlier and eps grew 43.3% from $-0.67.
- Where can I find Senti Biosciences's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001628280-26-021578) and the 10-K periodic report (0001628280-26-021580) directly on SEC EDGAR. The filing index links above go to sec.gov.
